From stage I to stage IV, the expression of IL-13 gradually decreased in LUAD (Figure 6B) and LUSC (Figure 6C) specimens, indicating that the changes in the IL-13 level can serve in evaluation of NSCLC. Here, IL13 is linked to non-small cell lung carcinoma.